N. Mekhail, Shrif J Costandi, A. Abd-Elsayed, G. Fiore, Jijun Xu, Lou-Anne Acevedo-Moreno, L. Kapural, A. Rezai, C. Gilligan
{"title":"Is Neuraxial Clonidine a Safer Alternative to Opioids for Chronic Pain? An Alternative Worth Exploring","authors":"N. Mekhail, Shrif J Costandi, A. Abd-Elsayed, G. Fiore, Jijun Xu, Lou-Anne Acevedo-Moreno, L. Kapural, A. Rezai, C. Gilligan","doi":"10.31487/j.nnb.2020.03.09","DOIUrl":null,"url":null,"abstract":"Objective: Exploring the potential role of clonidine as an alternative to the currently available neuraxial\nmedication options for the management of chronic pain.\nMethods: A comprehensive literature search was conducted investigating the treatment of chronic pain\nusing clonidine over the past 73 years. A stepwise filtering approach was used to obtain articles addressing\nneuraxial treatment of chronic pain in adults. Selected articles were assessed for their levels of evidence\nfollowed by a discussion of their contribution to the understanding of the role of clonidine in chronic pain\nmanagement.\nResults: Out of 1,035 articles that described the administration of clonidine for chronic pain management,\nseven articles met all of the inclusion criteria. Their levels of evidence ranged from 1a to 4 (Oxford Centre\nCEBM). Neuraxial administration of clonidine was found to be effective in the treatment of chronic pain,\noften exhibiting a synergistic effect with other analgesics to provide pain reduction with reduced opioid use.\nThe most common side effect was hypotension, in some cases reported to have been serious.\nConclusion: The use of neuraxial clonidine, in either a primary or adjunctive role, appears promising as an\neffective treatment for chronic pain.","PeriodicalId":19179,"journal":{"name":"Neurology and Neurobiology","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology and Neurobiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31487/j.nnb.2020.03.09","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Exploring the potential role of clonidine as an alternative to the currently available neuraxial
medication options for the management of chronic pain.
Methods: A comprehensive literature search was conducted investigating the treatment of chronic pain
using clonidine over the past 73 years. A stepwise filtering approach was used to obtain articles addressing
neuraxial treatment of chronic pain in adults. Selected articles were assessed for their levels of evidence
followed by a discussion of their contribution to the understanding of the role of clonidine in chronic pain
management.
Results: Out of 1,035 articles that described the administration of clonidine for chronic pain management,
seven articles met all of the inclusion criteria. Their levels of evidence ranged from 1a to 4 (Oxford Centre
CEBM). Neuraxial administration of clonidine was found to be effective in the treatment of chronic pain,
often exhibiting a synergistic effect with other analgesics to provide pain reduction with reduced opioid use.
The most common side effect was hypotension, in some cases reported to have been serious.
Conclusion: The use of neuraxial clonidine, in either a primary or adjunctive role, appears promising as an
effective treatment for chronic pain.